| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 178.072 | 197.573 | 221.485 | 260.805 | 298.377 | 327.108 | 326.526 | 372.118 | 407.485 |
| Total Income - EUR | - | 182.347 | 204.242 | 225.473 | 268.857 | 299.992 | 329.442 | 328.182 | 440.392 | 407.985 |
| Total Expenses - EUR | - | 142.788 | 170.328 | 171.948 | 221.528 | 220.873 | 239.629 | 263.350 | 302.963 | 341.390 |
| Gross Profit/Loss - EUR | - | 39.559 | 33.914 | 53.525 | 47.329 | 79.119 | 89.812 | 64.832 | 137.429 | 66.596 |
| Net Profit/Loss - EUR | - | 33.382 | 31.997 | 51.247 | 44.657 | 76.451 | 87.374 | 62.237 | 133.994 | 55.772 |
| Employees | - | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
Check the financial reports for the company - Clavirox Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 12.488 | 16.073 | 21.349 | 85.556 | 90.380 | 82.330 | 70.818 | 64.658 | 71.739 |
| Current Assets | - | 70.193 | 79.077 | 126.808 | 129.723 | 185.951 | 186.030 | 149.749 | 237.637 | 184.580 |
| Inventories | - | 22.284 | 20.598 | 19.542 | 30.778 | 52.837 | 73.545 | 54.938 | 60.280 | 63.216 |
| Receivables | - | 15.000 | 28.872 | 25.313 | 24.598 | 39.186 | 56.010 | 50.936 | 159.427 | 72.661 |
| Cash | - | 32.909 | 29.607 | 81.953 | 74.347 | 93.928 | 56.476 | 43.875 | 17.930 | 48.703 |
| Shareholders Funds | - | 33.427 | 31.563 | 82.230 | 125.295 | 188.414 | 190.314 | 62.286 | 196.091 | 125.593 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 49.321 | 63.628 | 65.927 | 89.983 | 87.917 | 78.046 | 158.281 | 106.203 | 130.726 |
| Income in Advance | - | 23 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Clavirox Medical Srl